Despite increasing use of artificial intelligence (AI) in health care, a new study led by Mass General Brigham researchers ...

As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.

The advent of high-density recording technologies, such as Neuropixels and large-scale calcium imaging, has provided an unprecedented look into the ...

Bio (NASDAQ:IBIO) is seeking to narrow what it views as a growing “trust gap” between the promise of generative AI in drug discovery and the high cost and long timelines of bringing a drug to market, ...

While precision seems critical for science, researchers from the U.S. Department of Energy's (DOE) Brookhaven National ...

The 2026 season of the Pharma.AI webinar series will showcase the ongoing AI revolution in life sciences, including the ...

As the CEO of a company that offers AI solutions, I've found that most of the public conversation surrounding AI still ...

Stanford University researchers today released their highly anticipated 2026 AI Index Report, revealing a global landscape where artificial intelligence technology is being adopted at record-breaking ...

According to MarketsandMarkets™, the Generative AI Server Market is expected to reach USD 448.60 billion by 2030 from USD 103.92 billion in 2025, registering a CAGR of 34.0% during the forecast period ...

PR Newswire reports on how AI alters brand perception, urging PR teams to measure AI visibility through mentions, sources, and AI-generated descriptions.

How do we design assignments AI can’t complete? These are real questions. But they start in the wrong place. The deeper ...